Login Register Cart 0
Generic placeholder image

Current Nanomaterials

Editor-in-Chief

ISSN (Print): 2405-4615
ISSN (Online): 2405-4623

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Cytotoxic Effect of Podophyllotoxin-Loaded Magnetic Nanoparticles on Proliferation of Colorectal (HT-29) and Breast (MCF-7) Cancer Cell Lines

Author(s): Mahboubeh Mansourian, Sayed Mehdi Peimanimotlagh, Mehrorang Ghaedi, Mohammad Sharif Talebianpoor, Zeinab Salehpour, Ghasem Ghalamfarsa, Maryam Tajali Ardakani and Hassan Bardania*

Volume 8, Issue 1, 2023

Published on: 17 March, 2022

Page: [82 - 89] Pages: 8

DOI: 10.2174/2405461507666220204100719

Price: $65

Abstract

Background: Treatment used for cancer is generally associated with serious side effects. New solutions for cancer therapy can overcome the shortcomings and problems of conventional therapies by designing drug delivery nanosystems.

Methods: In this study, magnetic Fe3O4@AU@albumin core-shell-shell (CSS) nanoparticles were synthesized and characterized by various analyses, such as transmission electron microscopy (TEM), X-ray diffraction (XRD), and vibrating sample magnetization (VSM). Podophyllotoxin (PPT) was then loaded on magnetic nanoparticles as an anti-cancer drug and its effect on HT-29 and MCF-7 cell lines was evaluated using an MTT assay.

Results: The crystallinity of synthesized Fe3O4 magnetic nanoparticles was confirmed by XRD analysis. Next, a layer of gold was coated with the Fe3O4 MNPs. The UV-Vis analysis of core-shell nanoparticles (iron oxide/gold) confirmed the successful synthesis of these nanoparticles. The surface of the core-shell nanoparticles was then coated with albumin to load the drug. TEM image confirmed the existence of albumin nanoparticles loaded with core-shell magnetic nanoparticles. VSM analysis revealed that iron oxide, Fe3O4@AU, and Fe3O4@AU@albumin nanoparticles have the highest magnetic properties, respectively. After the synthesis of PPT loaded onto MNP, the loading efficiency was found to be 50%. The IC50 values of PPT alone and loaded onto nanoparticles on MCF-7 cells after 24 hours were 3085.75 and 1868.09 nM, respectively, which were significantly toxic (P-value ≤ 0.05) but not significant after 48 hours. The PPT loaded on nanoparticles was found to be significantly more toxic to HT-29 cells after 24 and 48 h than PPT alone (P-value ≤ 0.05).

Conclusion: The anticancer drug of PPT-loaded MNPs has significant advantages over PPT alone due to its improved properties with appropriate cytotoxic activity. Thus, the PPT-loaded MNPs may be considered effective anti-cancer agents for further research on drug development.

Keywords: Magnetic nanoparticles, colorectal cancer, breast cancer, cell lines, F3O4 magnetic NPs, core shell nanoparticles.

« Previous
Graphical Abstract

[1]
Institute NC. Cancer Trends Progress Report 2011/2012 Update MD National Cancer Institute Bethesda. 2012.
[2]
Pillai G. Nanotechnology toward treating cancer: A comprehensive review. In: Shyam SM, Shivendu R, Sabu T, Eds.Applications of Targeted Nano Drugs and Delivery Systems. 2019; pp. 221-56.
[3]
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893-917.
[http://dx.doi.org/10.1002/ijc.25516] [PMID: 21351269]
[4]
Jain V, Jain S, Mahajan SC. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment. Curr Drug Deliv 2015; 12(2): 177-91.
[http://dx.doi.org/10.2174/1567201811666140822112516] [PMID: 25146439]
[5]
Safari J, Zarnegar Z. Advanced drug delivery systems: Nanotechnology of health design A review. J Saudi Chem Soc 2014; 18(2): 85-99.
[http://dx.doi.org/10.1016/j.jscs.2012.12.009]
[6]
Ardalani H, Avan A, Ghayour-Mobarhan M. Podophyllotoxin: A novel potential natural anticancer agent. Avicenna J Phytomed 2017; 7(4): 285-94.
[PMID: 28884079]
[7]
Liu YQ, Yang L, Tian X. Podophyllotoxin: Current perspectives. Curr Bioact Compd 2007; 3(1): 37-66.
[http://dx.doi.org/10.2174/157340707780126499]
[8]
Lundberg B. The solubilization of lipophilic derivatives of podophyllotoxins in sub-micron sized lipid emulsions and their cytotoxic activity against cancer cells in culture. Int J Pharm 1994; 109(1): 73-81.
[http://dx.doi.org/10.1016/0378-5173(94)90122-8]
[9]
Ha W, Zhao XB, Zhao WH, Tang JJ, Shi YP. A colon-targeted podophyllotoxin nanoprodrug: Synthesis, characterization, and supramolecular hydrogel formation for the drug combination. J Mater Chem B Mater Biol Med 2021; 9(14): 3200-9.
[http://dx.doi.org/10.1039/D0TB02719G] [PMID: 33885624]
[10]
Sk UH, Patial V, Sharma S. A low toxic synthetic dendrimer conjugated podophyllotoxin nanodevice with potent antitumor activity against the DMBA/TPA induced mouse skin carcinogenesis model. Toxicol Res (Camb) 2015; 4(5): 1204-13.
[http://dx.doi.org/10.1039/C5TX00112A]
[11]
Zhu S, Zhen H, Li Y, Wang P, Huang X, Shi P. PEGylated graphene oxide as a nanocarrier for podophyllotoxin. J Nanopart Res 2014; 16(8): 1-11.
[http://dx.doi.org/10.1007/s11051-014-2530-z]
[12]
Yadav R, Kumar D, Kumari A, Yadav SK. Encapsulation of podophyllotoxin and etoposide in biodegradable poly-D,L-lactide nanoparticles improved their anticancer activity. J Microencapsul 2014; 31(3): 211-9.
[http://dx.doi.org/10.3109/02652048.2013.834988] [PMID: 24102094]
[13]
Wang Y, Zhao B, Wang S, et al. Formulation and evaluation of novel glycyrrhizic acid micelles for transdermal delivery of podophyllotoxin. Drug Deliv 2016; 23(5): 1623-35.
[http://dx.doi.org/10.3109/10717544.2015.1135489] [PMID: 26786787]
[14]
Fathi Karkan S, Mohammadhosseini M, Panahi Y, et al. Magnetic nanoparticles in cancer diagnosis and treatment: A review. Artif Cells Nanomed Biotechnol 2017; 45(1): 1-5.
[http://dx.doi.org/10.3109/21691401.2016.1153483] [PMID: 27015806]
[15]
Tran N, Webster TJ. Magnetic nanoparticles: Biomedical applications and challenges. J Mater Chem 2010; 20(40): 8760-7.
[http://dx.doi.org/10.1039/c0jm00994f]
[16]
Dobson J. Magnetic nanoparticles for drug delivery. Drug Dev Res 2006; 67(1): 55-60.
[http://dx.doi.org/10.1002/ddr.20067]
[17]
Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res 2010; 62(2): 144-9.
[http://dx.doi.org/10.1016/j.phrs.2010.01.014] [PMID: 20149874]
[18]
Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008; 60(11): 1252-65.
[http://dx.doi.org/10.1016/j.addr.2008.03.018] [PMID: 18558452]
[19]
Veiseh O, Gunn JW, Zhang M. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev 2010; 62(3): 284-304.
[http://dx.doi.org/10.1016/j.addr.2009.11.002] [PMID: 19909778]
[20]
Wu W, Wu Z, Yu T, Jiang C, Kim WS. Recent progress on magnetic iron oxide nanoparticles: Synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater 2015; 16(2): 023501.
[http://dx.doi.org/10.1088/1468-6996/16/2/023501] [PMID: 27877761]
[21]
Wu A, Ou P, Zeng L. Biomedical applications of magnetic nanoparticles. Nano 2010; 5(05): 245-70.
[http://dx.doi.org/10.1142/S1793292010002165]
[22]
Danafar H, Sharafi A, Kheiri S, Kheiri Manjili H. Co-delivery of sulforaphane and curcumin with pegylated iron oxide-gold core shell nanoparticles for delivery to breast cancer cell line. Iran J Pharm Res 2018; 17(2): 480-94.
[PMID: 29881406]
[23]
Shujuan Y, Hongling Z, Junyan P, et al. Studies on the preparation, characterization and intracellular kinetics of JD27-loaded human serum albumin nanoparticles. Procedia Eng 2015; 102: 590-601.
[http://dx.doi.org/10.1016/j.proeng.2015.01.133]
[24]
Avachat AM, Oswal YM, Gujar KN, Shah RD. Preparation and characterization of rivastigmine loaded human serum albumin (HSA) nanoparticles. Curr Drug Deliv 2014; 11(3): 359-70.
[http://dx.doi.org/10.2174/15672018113109990050] [PMID: 24893995]
[25]
Gordaliza M, Castro MA, del Corral JM, Feliciano AS. Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 2000; 6(18): 1811-39.
[http://dx.doi.org/10.2174/1381612003398582] [PMID: 11102564]
[26]
Zhang X, Rakesh KP, Shantharam CS, et al. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs. Bioorg Med Chem 2018; 26(2): 340-55.
[http://dx.doi.org/10.1016/j.bmc.2017.11.026] [PMID: 29269253]
[27]
Qi YL, Liao F, Zhao CQ, Lin YD, Zuo MX. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells. Acta Pharmacol Sin 2005; 26(8): 1000-8.
[http://dx.doi.org/10.1111/j.1745-7254.2005.00148.x] [PMID: 16038635]
[28]
Bardania H, Raheb J, Mohammad-Beigi H, Rasekh B, Arpanaei A. Desulfurization activity and reusability of magnetite nanoparticle-coated Rhodococcus erythropolis FMF and R. erythropolis IGTS8 bacterial cells. Biotechnol Appl Biochem 2013; 60(3): 323-9.
[http://dx.doi.org/10.1002/bab.1090] [PMID: 23656694]
[29]
Bardania H, Raheb J, Arpanaei A. Investigation of desulfurization activity, reusability, and viability of magnetite coated bacterial cells. Iran J Biotechnol 2019; 17(2): e2108.
[http://dx.doi.org/10.21859/ijb.2108] [PMID: 31457057]
[30]
Baneshi M, Dadfarnia S, Shabani AMH, Sabbagh SK, Haghgoo S, Bardania H. A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery. Int J Pharm 2019; 564: 145-52.
[http://dx.doi.org/10.1016/j.ijpharm.2019.04.025] [PMID: 30978484]
[31]
Mohammad-Beigi H, Shojaosadati SA, Morshedi D, Mirzazadeh N, Arpanaei A. The effects of organic solvents on the physicochemical properties of human serum albumin nanoparticles. Iran J Biotechnol 2016; 14(1): 45-50.
[http://dx.doi.org/10.15171/ijb.1168] [PMID: 28959317]
[32]
Mahmoudi R, Hassandokht F, Ardakani MT, et al. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. J Biomater Appl 2021; 35(8): 1005-18.
[http://dx.doi.org/10.1177/0885328220976331] [PMID: 33283585]
[33]
Mahmoudi R, Ashraf Mirahmadi-Babaheidri S, Delaviz H, et al. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells. J Biomater Appl 2021; 35(7): 743-53.
[http://dx.doi.org/10.1177/0885328220949367] [PMID: 32807016]
[34]
Vikesland PJ, Heathcock AM, Rebodos RL, Makus KE. Particle size and aggregation effects on magnetite reactivity toward carbon tetrachloride. Environ Sci Technol 2007; 41(15): 5277-83.
[http://dx.doi.org/10.1021/es062082i] [PMID: 17822091]
[35]
Yousefzadi M, Sharifi M, Behmanesh M, et al. Podophyllotoxin: Current approaches to its bio-technological production and future challenges. Eng Life Sci 2010; 10(4): 281-92.
[http://dx.doi.org/10.1002/elsc.201000027]

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy